FDA APPROVED...Gazyva (obinutuzumab) for use i... - CLL Support
FDA APPROVED...Gazyva (obinutuzumab) for use in combination with chlorambucil to treat patients with previously untreated CLL.
You need to be a member of this community to see this post.
4 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Arzerra(R) (Ofatumumab) granted FDA 'Breakthrough Therapy Designation' for Previously Untreated CLL
Genmab A/S and GlaxoSmithKline plc (GSK) announced that the US Food and Drug Administration (FDA)...
Obinutuzumab likely first new kid on the block...
The FDA has granted Obinutuzumab GA101 in CLL both Breakthrough Therapy Designation and Priority...
Zydelig (idelalisib) first line... NO!
I have had a few emails and PMs asking about the use of Zydelig (idelalisib) for first line, since...
The convoluted history of Campath and when side effects can be useful
Here's a fascinating article about off-label use of Campath (from Cambridge Pathology), a...
Adding Venetoclax to Obinutuzumab Prolongs Progression-Free Survival in Previously Untreated CLL
Dated 1st September 2019
In a phase III trial of patients with previously untreated CLL...
Zanubrutinib Bests Bendamustine-Rituximab in Previously Untreated CLL/SLL
quinine to treat cramps and cll patients.
The future is looking brighter for untreated CLL patients. 
